908 Devices (MASS) Competitors $6.42 -0.13 (-1.98%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$6.41 -0.01 (-0.16%) As of 08/1/2025 04:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MASS vs. TRNS, EYPT, ALNT, AEHR, LAB, CTKB, SENS, QSI, QTRX, and FEIMShould you be buying 908 Devices stock or one of its competitors? The main competitors of 908 Devices include Transcat (TRNS), Eyepoint Pharmaceuticals (EYPT), Allient (ALNT), Aehr Test Systems (AEHR), Standard BioTools (LAB), Cytek Biosciences (CTKB), Senseonics (SENS), Quantum-Si (QSI), Quanterix (QTRX), and Frequency Electronics (FEIM). These companies are all part of the "measuring and control equipment" industry. 908 Devices vs. Its Competitors Transcat Eyepoint Pharmaceuticals Allient Aehr Test Systems Standard BioTools Cytek Biosciences Senseonics Quantum-Si Quanterix Frequency Electronics Transcat (NASDAQ:TRNS) and 908 Devices (NASDAQ:MASS) are both small-cap measuring and control equipment companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, analyst recommendations, media sentiment, institutional ownership, dividends, risk and profitability. Which has more volatility & risk, TRNS or MASS? Transcat has a beta of 0.71, meaning that its stock price is 29% less volatile than the S&P 500. Comparatively, 908 Devices has a beta of 0.37, meaning that its stock price is 63% less volatile than the S&P 500. Do insiders and institutionals believe in TRNS or MASS? 98.3% of Transcat shares are held by institutional investors. Comparatively, 88.1% of 908 Devices shares are held by institutional investors. 2.8% of Transcat shares are held by company insiders. Comparatively, 23.7% of 908 Devices shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Is TRNS or MASS more profitable? Transcat has a net margin of 5.21% compared to 908 Devices' net margin of -28.80%. Transcat's return on equity of 6.47% beat 908 Devices' return on equity.Company Net Margins Return on Equity Return on Assets Transcat5.21% 6.47% 5.02% 908 Devices -28.80%-27.10%-20.49% Which has better valuation and earnings, TRNS or MASS? Transcat has higher revenue and earnings than 908 Devices. 908 Devices is trading at a lower price-to-earnings ratio than Transcat, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTranscat$278.42M2.50$14.52M$1.5647.79908 Devices$59.63M3.86-$72.21M-$0.54-11.89 Do analysts rate TRNS or MASS? Transcat presently has a consensus target price of $112.20, suggesting a potential upside of 50.50%. 908 Devices has a consensus target price of $5.33, suggesting a potential downside of 16.93%. Given Transcat's stronger consensus rating and higher possible upside, equities research analysts plainly believe Transcat is more favorable than 908 Devices.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Transcat 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60908 Devices 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50 Does the media refer more to TRNS or MASS? In the previous week, 908 Devices had 2 more articles in the media than Transcat. MarketBeat recorded 7 mentions for 908 Devices and 5 mentions for Transcat. 908 Devices' average media sentiment score of 1.02 beat Transcat's score of 0.59 indicating that 908 Devices is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Transcat 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive 908 Devices 3 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryTranscat beats 908 Devices on 12 of the 16 factors compared between the two stocks. Get 908 Devices News Delivered to You Automatically Sign up to receive the latest news and ratings for MASS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MASS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MASS vs. The Competition Export to ExcelMetric908 DevicesMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$234.89M$6.76B$5.49B$9.52BDividend YieldN/A1.32%4.73%4.09%P/E Ratio-11.8920.9428.7823.81Price / Sales3.8654.12372.2066.04Price / CashN/A20.5035.4557.96Price / Book1.954.468.275.54Net Income-$72.21M$174.54M$3.25B$259.28M7 Day Performance-13.48%-5.27%-3.70%-4.64%1 Month Performance-2.87%-3.94%4.34%4.41%1 Year Performance31.56%8.26%25.90%17.95% 908 Devices Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MASS908 Devices2.0947 of 5 stars$6.42-2.0%$5.33-16.9%+26.4%$234.89M$59.63M-11.8960Positive NewsUpcoming EarningsAnalyst ForecastGap DownTRNSTranscat3.3122 of 5 stars$82.71-1.7%$112.20+35.7%-32.9%$770.69M$278.42M53.021,245Upcoming EarningsEYPTEyepoint Pharmaceuticals1.91 of 5 stars$10.03-4.3%$25.67+155.9%+6.4%$690.16M$43.27M-4.16120News CoverageUpcoming EarningsALNTAllient2.3064 of 5 stars$39.91+0.4%$31.00-22.3%+38.5%$675.68M$529.97M67.652,525News CoveragePositive NewsUpcoming EarningsGap DownAEHRAehr Test Systems1.6485 of 5 stars$20.91-3.8%N/A+1.8%$622.51M$58.97M-160.8390Gap DownLABStandard BioTools3.3857 of 5 stars$1.42+1.4%$2.50+76.1%-8.5%$539.34M$174.43M-4.06620News CoveragePositive NewsGap DownCTKBCytek Biosciences2.344 of 5 stars$3.75+1.6%$5.60+49.3%-43.2%$474.98M$200.45M-41.66500Positive NewsUpcoming EarningsSENSSenseonics1.6234 of 5 stars$0.54-2.2%$1.55+187.0%+21.1%$353.34M$23.68M-4.1590QSIQuantum-Si2.5321 of 5 stars$1.79-7.3%$3.48+94.1%+47.6%$328.47M$3.06M-2.63150Upcoming EarningsGap DownQTRXQuanterix2.2462 of 5 stars$6.49+10.9%$13.50+108.0%-58.3%$324.20M$133.92M-4.99460Upcoming EarningsGap DownFEIMFrequency Electronics1.0606 of 5 stars$27.87-0.4%N/A+99.3%$271.12M$69.81M11.28200Short Interest ↑Gap DownHigh Trading Volume Related Companies and Tools Related Companies Transcat Alternatives Eyepoint Pharmaceuticals Alternatives Allient Alternatives Aehr Test Systems Alternatives Standard BioTools Alternatives Cytek Biosciences Alternatives Senseonics Alternatives Quantum-Si Alternatives Quanterix Alternatives Frequency Electronics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MASS) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 908 Devices Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share 908 Devices With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.